Repare Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Repare Therapeutics Inc. (RPTX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-84.69-93.80-29.05-106.91-53.42
Depreciation & Amortization1.921.951.981.470.90
Stock Based Compensation23.1725.0619.6912.832.54
Change in Working Capital-14.06-55.184.417.0043.70
Change in Accounts Receivable2.72-0.22-1.390.00-2.04
Change in Accounts Payable1.231.93-1.350.150.02
Change in Other Working Capital2.361.262.1712.81-3.94
Other Operating Activities2.362.275.53-0.320.20
Net Cash from Operating Activities-76.45-127.160.32-85.80-6.08
Investing Activities
Capital Expenditures0.00-1.94-0.60-1.69-2.24
Purchases of Investments-133.3679.98-175.18-0.03-7.53
Sales/Maturities of Investments182.82259.0081.407.450.00
Net Cash from Investing Activities49.4778.04-175.78-1.68-9.76
Financing Activities
Common Stock Issued0.540.840.8895.56232.84
Other Financing Activities0.000.000.000.0015.00
Net Cash from Financing Activities0.540.840.8895.56247.84
Summary
Effect of Forex Changes on Cash-0.120.02-0.33-0.050.00
Net Change in Cash-26.44-48.25-174.918.03231.39
Cash at Beginning of Period111.27159.52334.43326.400.00
Cash at End of Period84.72111.27159.52334.430.00
Free Cash Flow-76.45-129.10-0.28-87.49-8.32
Supplemental Disclosures
Income Taxes Paid0.000.0010.810.030.16